Use of neuropeptide y1 receptor binding compounds in the treatment and diagnosis of cancer

摘要

The present invention relates to the use of compounds that bind the neuropeptide Y₁ (NPY₁) receptor for the preparation of a pharmaceutical composition for the diagnosis or treatment of tumors expressing NPY₁ receptors, in particular breast cancer, ovarian cancer and glioblastoma. The invention also relates to the pharmaceutical compositions that contain such compounds.